171 related articles for article (PubMed ID: 7877149)
1. Structural and conformational requirements for human calcitonin activity: design, synthesis, and study of lactam-bridged analogues.
Kapurniotu A; Taylor JW
J Med Chem; 1995 Mar; 38(5):836-47. PubMed ID: 7877149
[TBL] [Abstract][Full Text] [Related]
2. Side-chain lactam-bridge conformational constraints differentiate the activities of salmon and human calcitonins and reveal a new design concept for potent calcitonin analogues.
Taylor JW; Jin QK; Sbacchi M; Wang L; Belfiore P; Garnier M; Kazantzis A; Kapurniotu A; Zaratin PF; Scheideler MA
J Med Chem; 2002 Feb; 45(5):1108-21. PubMed ID: 11855991
[TBL] [Abstract][Full Text] [Related]
3. Conformationally constrained human calcitonin (hCt) analogues reveal a critical role of sequence 17-21 for the oligomerization state and bioactivity of hCt.
Kazantzis A; Waldner M; Taylor JW; Kapurniotu A
Eur J Biochem; 2002 Feb; 269(3):780-91. PubMed ID: 11846779
[TBL] [Abstract][Full Text] [Related]
4. Rational design, conformational studies and bioactivity of highly potent conformationally constrained calcitonin analogues.
Kapurniotu A; Kayed R; Taylor JW; Voelter W
Eur J Biochem; 1999 Oct; 265(2):606-18. PubMed ID: 10504392
[TBL] [Abstract][Full Text] [Related]
5. Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation.
Houssami S; Findlay DM; Brady CL; Martin TJ; Epand RM; Moore EE; Murayama E; Tamura T; Orlowski RC; Sexton PM
Mol Pharmacol; 1995 Apr; 47(4):798-809. PubMed ID: 7723741
[TBL] [Abstract][Full Text] [Related]
6. Deletion sequences of salmon calcitonin that retain the essential biological and conformational features of the intact molecule.
Epand RM; Epand RF; Stafford AR; Orlowski RC
J Med Chem; 1988 Aug; 31(8):1595-8. PubMed ID: 3397998
[TBL] [Abstract][Full Text] [Related]
7. Biologically potent analogues of salmon calcitonin which do not contain an N-terminal disulfide-bridged ring structure.
Orlowski RC; Epand RM; Stafford AR
Eur J Biochem; 1987 Jan; 162(2):399-402. PubMed ID: 3803393
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and characterization of a model peptide having potent calcitonin-like biological activity: implications for calcitonin structure/activity.
Moe GR; Kaiser ET
Biochemistry; 1985 Apr; 24(8):1971-6. PubMed ID: 2990546
[TBL] [Abstract][Full Text] [Related]
9. Correlations between biological activities and conformational properties for human, salmon, eel, porcine calcitonins and Elcatonin elucidated by CD spectroscopy.
Siligardi G; Samorí B; Melandri S; Visconti M; Drake AF
Eur J Biochem; 1994 May; 221(3):1117-25. PubMed ID: 8181470
[TBL] [Abstract][Full Text] [Related]
10. Structure and activities of constrained analogues of human parathyroid hormone and parathyroid hormone-related peptide: implications for receptor-activating conformations of the hormones.
Barbier JR; MacLean S; Morley P; Whitfield JF; Willick GE
Biochemistry; 2000 Nov; 39(47):14522-30. PubMed ID: 11087406
[TBL] [Abstract][Full Text] [Related]
11. Constrained corticotropin-releasing factor (CRF) agonists and antagonists with i-(i+3) Glu-Xaa-DXbb-Lys bridges.
Koerber SC; Gulyas J; Lahrichi SL; Corrigan A; Craig AG; Rivier C; Vale W; Rivier J
J Med Chem; 1998 Dec; 41(25):5002-11. PubMed ID: 9836618
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological activities of cyclic lactam peptide analogues of dynorphine A(1-11)-NH2.
Lung FD; Collins N; Stropova D; Davis P; Yamamura HI; Porreca F; Hruby VJ
J Med Chem; 1996 Mar; 39(5):1136-41. PubMed ID: 8676350
[TBL] [Abstract][Full Text] [Related]
13. Conformational transitions and fibrillation mechanism of human calcitonin as studied by high-resolution solid-state 13C NMR.
Kamihira M; Naito A; Tuzi S; Nosaka AY; Saitô H
Protein Sci; 2000 May; 9(5):867-77. PubMed ID: 10850796
[TBL] [Abstract][Full Text] [Related]
14. Analogue separates biological effects of salmon calcitonin on brain and renal cortical membranes.
Twery MJ; Seitz PK; Nickols GA; Cooper CW; Gallagher JP; Orlowski RC
Eur J Pharmacol; 1988 Oct; 155(3):285-92. PubMed ID: 3266153
[TBL] [Abstract][Full Text] [Related]
15. A new approach to search for the bioactive conformation of glucagon: positional cyclization scanning.
Ahn JM; Gitu PM; Medeiros M; Swift JR; Trivedi D; Hruby VJ
J Med Chem; 2001 Sep; 44(19):3109-16. PubMed ID: 11543679
[TBL] [Abstract][Full Text] [Related]
16. Conformational analysis of elcatonin in solution.
Ogawa K; Nishimura S; Doi M; Kyogoku Y; Hayashi M; Kobayashi Y
Eur J Biochem; 1994 Jun; 222(2):659-66. PubMed ID: 8020504
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of human and salmon calcitonin secondary structure in solutions with low dielectric constants.
Arvinte T; Drake AF
J Biol Chem; 1993 Mar; 268(9):6408-14. PubMed ID: 8454613
[TBL] [Abstract][Full Text] [Related]
18. Biological properties of two models of calcitonin gene related peptide with idealized amphiphilic alpha-helices of different lengths.
Lynch B; Kaiser ET
Biochemistry; 1988 Oct; 27(20):7600-7. PubMed ID: 3264724
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity studies on position 14 of human alpha-calcitonin gene-related peptide.
Li J; Matsuura JE; Waugh DJ; Adrian TE; Abel PW; Manning MC; Smith DD
J Med Chem; 1997 Sep; 40(19):3071-6. PubMed ID: 9301670
[TBL] [Abstract][Full Text] [Related]
20. Fluorescent Analogues of Human α-Calcitonin Gene-Related Peptide with Potent Vasodilator Activity.
Zhu J; Pedersen MD; Ahmed LS; Abdolalizadeh B; Grell AS; Berg JO; Thulstrup PW; Franzyk H; Edvinsson L; Sams A; Sheykhzade M; Hansen PR
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32079247
[No Abstract] [Full Text] [Related]
[Next] [New Search]
